NO20024223L - Monoklonale antistoffer til den humane LDL-reseptor, deres fremstilling og anvendelse - Google Patents

Monoklonale antistoffer til den humane LDL-reseptor, deres fremstilling og anvendelse

Info

Publication number
NO20024223L
NO20024223L NO20024223A NO20024223A NO20024223L NO 20024223 L NO20024223 L NO 20024223L NO 20024223 A NO20024223 A NO 20024223A NO 20024223 A NO20024223 A NO 20024223A NO 20024223 L NO20024223 L NO 20024223L
Authority
NO
Norway
Prior art keywords
preparation
monoclonal antibodies
ldl receptor
human ldl
human
Prior art date
Application number
NO20024223A
Other languages
English (en)
Other versions
NO20024223D0 (no
NO330904B1 (no
Inventor
Michel Dreano
Nachum Yonah
Dany Suissa
Ilana Belzer
Moshe Smolarsky
Francesco Antonetti
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26323933&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20024223(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from IL13502500A external-priority patent/IL135025A0/xx
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of NO20024223D0 publication Critical patent/NO20024223D0/no
Publication of NO20024223L publication Critical patent/NO20024223L/no
Publication of NO330904B1 publication Critical patent/NO330904B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20024223A 2000-03-13 2002-09-04 Monoklonalt antistoff, kimerisk antistoff, fullt humanisert antistoff, anti-anti-ID-antistoff eller fragment derav som binder human loselig LDL-reseptor, anvendelse av samme som medikament og fremstilling og av et medikament til behandling av hepatitt-C-infeksjon, hybridomkloner, fremgangsmate pavisning og/eller kvantifisering av human loselig LDLR, for fremstilling av et monoklonalt antistoff, for rensing av human LDLR, og in vitro-fremgangsmate for inhibering av replikasjon av hepatitt-C-virus. NO330904B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL13502500A IL135025A0 (en) 2000-03-13 2000-03-13 Monoclonal antibodies to the human ldl receptor, their production and use
IL13921700A IL139217A0 (en) 2000-03-13 2000-10-23 Monoclonal antibodies to the human ldl receptor, their production and use
PCT/IL2001/000216 WO2001068710A1 (en) 2000-03-13 2001-03-08 Monoclonal antibodies to the human ldl receptor, their production and use

Publications (3)

Publication Number Publication Date
NO20024223D0 NO20024223D0 (no) 2002-09-04
NO20024223L true NO20024223L (no) 2002-10-24
NO330904B1 NO330904B1 (no) 2011-08-15

Family

ID=26323933

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024223A NO330904B1 (no) 2000-03-13 2002-09-04 Monoklonalt antistoff, kimerisk antistoff, fullt humanisert antistoff, anti-anti-ID-antistoff eller fragment derav som binder human loselig LDL-reseptor, anvendelse av samme som medikament og fremstilling og av et medikament til behandling av hepatitt-C-infeksjon, hybridomkloner, fremgangsmate pavisning og/eller kvantifisering av human loselig LDLR, for fremstilling av et monoklonalt antistoff, for rensing av human LDLR, og in vitro-fremgangsmate for inhibering av replikasjon av hepatitt-C-virus.

Country Status (33)

Country Link
US (1) US6849720B2 (no)
EP (1) EP1263790B1 (no)
JP (1) JP4768193B2 (no)
KR (1) KR100882081B1 (no)
CN (1) CN1418225B (no)
AR (1) AR028518A1 (no)
AT (1) ATE362490T1 (no)
AU (2) AU4100201A (no)
BG (1) BG65762B1 (no)
BR (1) BR0109164A (no)
CA (1) CA2402593C (no)
CY (1) CY1108020T1 (no)
CZ (1) CZ20023098A3 (no)
DE (1) DE60128452T2 (no)
DK (1) DK1263790T3 (no)
EA (1) EA007494B1 (no)
EE (1) EE200200517A (no)
ES (1) ES2282238T3 (no)
HK (1) HK1055750A1 (no)
HR (1) HRP20020704B1 (no)
HU (1) HU226194B1 (no)
IL (2) IL139217A0 (no)
MX (1) MXPA02009091A (no)
NO (1) NO330904B1 (no)
NZ (1) NZ520944A (no)
PL (1) PL206041B1 (no)
PT (1) PT1263790E (no)
RS (1) RS51406B (no)
SI (1) SI1263790T1 (no)
SK (1) SK287348B6 (no)
UA (1) UA78489C2 (no)
WO (1) WO2001068710A1 (no)
ZA (1) ZA200206654B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0114629D0 (en) * 2001-06-15 2001-08-08 Pfizer Ltd Method
US7598046B2 (en) 2003-06-19 2009-10-06 Laboratories Serono Sa Use of prion conversion modulating agents
FR2889533B1 (fr) * 2005-08-03 2007-10-12 Lab Francais Du Fractionnement Anticorps diriges contre le recepteur du ldl
FR2889532B1 (fr) * 2005-08-03 2007-10-12 Lab Francais Du Fractionnement Anticorps diriges contre le recepteur du ldl
EP1991869A2 (en) * 2006-02-17 2008-11-19 Paolo La Colla Methods for the diagnosis of proliferative and/or conformational diseases
FR2910896B1 (fr) * 2006-12-29 2012-11-16 Lab Francais Du Fractionnement Anticorps monoclonal dirige contre le recepteur humain des ldl
IL182956A0 (en) 2007-05-03 2008-01-20 Yeda Res & Dev Glycan modified soluble receptors and binding proteins and their use
IL188628A0 (en) * 2008-01-07 2008-12-29 Yeda Res & Dev Use of soluble ldl-r for viral hepatitis
GB0922377D0 (en) * 2009-12-22 2010-02-03 Arab Gulf University The Mutant LDL receptor
US20130129676A1 (en) 2010-05-25 2013-05-23 Universite De Strasbourg Combination of anti-envelope antibodies and anti-receptor antibodies for the treatment and prevention of hcv infection
WO2013024156A2 (en) 2011-08-17 2013-02-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Combinations of anti-hcv-entry factor antibodies and interferons for the treatment and the prevention of hcv infection
WO2013024157A2 (en) 2011-08-17 2013-02-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Combinations of host targeting agents for the treatment and the prevention of hcv infection
WO2013024155A1 (en) 2011-08-17 2013-02-21 Inserm (Institut National De La Sante Et De La Recherche Medicale) Combinations of anti-hcv-entry factor antibodies and direct acting antivirals for the treatment and the prevention of hcv infection
CN103111270B (zh) * 2013-02-26 2015-06-10 王业富 一种乙型肝炎抗原蛋白的吸附材料及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5182364A (en) * 1990-02-26 1993-01-26 The Scripps Research Institute Polypeptide analogs of apolipoprotein E
US5496926A (en) * 1992-01-19 1996-03-05 Yeda Research And Development Co. Ltd. Process of preparing a soluble LDL receptor
US5945308A (en) * 1998-04-03 1999-08-31 Incyte Pharmaceuticals, Inc. Human oxidized LDL receptor
JP2000279174A (ja) * 1999-03-30 2000-10-10 Bml Inc ヒトｌｄｌレセプターに対するモノクローナル抗体及びこれを用いる家族性高脂血症の判定方法

Also Published As

Publication number Publication date
JP4768193B2 (ja) 2011-09-07
HU226194B1 (hu) 2008-06-30
ZA200206654B (en) 2003-10-20
NO20024223D0 (no) 2002-09-04
CN1418225A (zh) 2003-05-14
BR0109164A (pt) 2002-11-26
AU4100201A (en) 2001-09-24
CZ20023098A3 (cs) 2003-02-12
PL358381A1 (en) 2004-08-09
US20030186343A1 (en) 2003-10-02
EA200200974A1 (ru) 2003-02-27
CA2402593C (en) 2012-07-03
EP1263790A1 (en) 2002-12-11
UA78489C2 (en) 2007-04-10
ES2282238T3 (es) 2007-10-16
PT1263790E (pt) 2007-06-01
SK287348B6 (sk) 2010-08-09
DE60128452T2 (de) 2007-09-13
BG107063A (bg) 2003-05-30
MXPA02009091A (es) 2005-06-20
EA007494B1 (ru) 2006-10-27
EP1263790B1 (en) 2007-05-16
BG65762B1 (bg) 2009-10-30
CA2402593A1 (en) 2001-09-20
IL151713A0 (en) 2003-04-10
AU2001241002B8 (en) 2006-05-04
CN1418225B (zh) 2012-04-18
RS51406B (sr) 2011-02-28
AU2001241002B2 (en) 2006-04-06
SK13122002A3 (sk) 2003-04-01
US6849720B2 (en) 2005-02-01
KR100882081B1 (ko) 2009-02-10
NO330904B1 (no) 2011-08-15
DK1263790T3 (da) 2007-07-02
EE200200517A (et) 2004-02-16
YU68602A (sh) 2006-03-03
KR20020089384A (ko) 2002-11-29
AR028518A1 (es) 2003-05-14
HUP0300142A3 (en) 2005-07-28
HRP20020704B1 (en) 2011-01-31
PL206041B1 (pl) 2010-06-30
DE60128452D1 (de) 2007-06-28
HRP20020704A2 (en) 2004-12-31
CY1108020T1 (el) 2013-09-04
IL139217A0 (en) 2001-11-25
WO2001068710A1 (en) 2001-09-20
ATE362490T1 (de) 2007-06-15
SI1263790T1 (sl) 2007-10-31
JP2004506603A (ja) 2004-03-04
HUP0300142A2 (hu) 2003-06-28
NZ520944A (en) 2004-04-30
HK1055750A1 (en) 2004-01-21

Similar Documents

Publication Publication Date Title
DK1957539T3 (da) Humane monoklonale antistoffer til proteintyrosinkinase 7 (ptk7) og deres anvendelse
DK1432735T3 (da) Antagonistiske humane anti-htnfsf13b-antistoffer
IS6779A (is) Mannlíkt mótefni gegn LT-beta-R
MXPA03001590A (es) Anticuerpos para la il-1beta humana.
DK1572946T3 (da) Terapeutisk humant monoklonalt anti-IL-1R1-antistof
NL1026829A1 (nl) Gemodificeerde humane IGF-1R-antilichamen.
DE60142500D1 (de) Humane monoklonale Antikörper gegen das kostimulatorische Signaltransduktionsmolekül AILIM und pharmazeutische Verwendungen davon
ATE480567T1 (de) Hochkonzentrierter antikörper und proteinformulierungen
NO20023788L (no) Antistoff som binder humant interleukin-18 samt fremgangsmater ved fremstilling og anvendelse derav
ATE458008T1 (de) Humane monoklonale antikörper gegen ctla-4
PT1177178E (pt) Benzimidazois hetereciclicos substituidos, sua preparacao e aplicacao
NO20015156L (no) 5-pyridyl-1,3-azolforbindelser, deres fremstilling og anvendelse
AR027976A1 (es) Anticuerpos humanos para cd154
ATE403439T1 (de) Lyophilisierte zubereitung enthaltend antikörper gegen den egf-rezeptor
NO20014603D0 (no) Tienopyrimidinforbindelser, deres fremstilling og anvendelse
ATE426616T1 (de) Antikírper gegen menschliches mcp-1
NO20024223L (no) Monoklonale antistoffer til den humane LDL-reseptor, deres fremstilling og anvendelse
NO20030111D0 (no) Kjemokinreseptor-modulatorer, deres fremstilling og anvendelse
NO20032542L (no) Dempede anti-CD28-antistoffer og anvendelse derav
NO20024105L (no) Memnopeptider, fremgangsmåte for deres fremstilling og anvendelse av disse
AR028262A1 (es) Anticuerpos especificos de fap-alfa humanos
IL135025A0 (en) Monoclonal antibodies to the human ldl receptor, their production and use
EE200300377A (et) Loomulikud HI-viiruse vastased antikehad
GB0017139D0 (en) Human monoclonal antibodies
GB0016824D0 (en) Human monoclonal antibodies

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS

MM1K Lapsed by not paying the annual fees